跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,516 条关于
“VRd”
全部
1,516
临床试验
985
药物
347
机构
7
资讯
177
去年
Isatuximab Combinations Show Promise in Newly Diagnosed Multiple Myeloma
2年前
Daratumumab-Based Regimens Deepen Responses and Improve MRD Negativity in Multiple Myeloma
去年
CEPHEUS Trial Supports Quadruplet Therapy with Daratumumab as New Standard in Multiple Myeloma
去年
Sarclisa Approved for First-Line Multiple Myeloma Treatment in Transplant-Ineligible Patients
去年
European Commission Approves Darzalex SC with VRd for Newly Diagnosed Multiple Myeloma
去年
Daratumumab Plus VRd Improves Outcomes in Transplant-Ineligible Multiple Myeloma Patients
去年
European Commission Approves Sanofi's Sarclisa with VRd for Newly Diagnosed Multiple Myeloma
去年
Belantamab Mafodotin Plus VRd Shows Promising Efficacy in Newly Diagnosed Multiple Myeloma
去年
FDA Issues Complete Response Letter for Darzalex Faspro in Newly Diagnosed Multiple Myeloma
2年前
FDA Approves Darzalex Faspro Quadruplet Regimen for Transplant-Eligible Multiple Myeloma
第 1 页,共 18 页
上一页
下一页